ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  O'Shea, Karen M ^a   Chess, David J ^a   Khairallah, Ramzi J ^a   Hecker, Peter A ^a   Lei, Biao ^a   Walsh, Kenneth ^b   Des Rosiers, Christine ^c   Stanley, William C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; MITOCHONDRIAL ENZYME; OMEGA 3 FATTY ACID; BIOLOGICAL MARKER; FATTY ACID; FETOPROTEIN; FISH OIL; MESSENGER RNA; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HEART; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE DILATION; HEART VENTRICLE FAILURE; MALE; MOUSE; NONHUMAN; SHAM FEEDING; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; DIET THERAPY; ECHOGRAPHY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART FAILURE; HEART MITOCHONDRION; HEART MUSCLE; HEART STROKE VOLUME; HYPERTENSION; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS; RATTUS;

ADIPONECTIN; ANIMALS; BIOLOGICAL MARKERS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FETAL PROTEINS; FISH OILS; GENE EXPRESSION REGULATION; HEART FAILURE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MYOCARDIUM; PHOSPHOLIPIDS; RNA, MESSENGER; STROKE VOLUME;

EID: 77956471181     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-95     Document Type: Article

References (37)

1. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. PM Kris-Etherton WS Harris LJ Appel, Circulation 2002 106 2747 2757
2. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. CJ Lavie RV Milani MR Mehra HO Ventura, J Am Coll Cardiol 2009 54 585 594
3. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. A Leaf JX Kang YF Xiao GE Billman, Circulation 2003 107 2646 2652
4. Fish intake and risk of incident heart failure. D Mozaffarian CL Bryson RN Lemaitre GL Burke DS Siscovick, J Am Coll Cardiol 2005 45 2015 2021 (Pubitemid 40814125)
5. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. L Tavazzi AP Maggioni R Marchioli S Barlera MG Franzosi R Latini, et al. Lancet 2008 372 1223 1230
6. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. MK Duda KM O'Shea B Lei BR Barrows AM Azimzadeh TE McElfresh, et al. Cardiovasc Res 2007 76 303 310
7. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. MK Duda KM O'Shea A Tintinu W Xu RJ Khairallah BR Barrows, et al. Cardiovasc Res 2009 81 319 327
8. omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. MK Duda KM O'Shea WC Stanley, Cardiovasc Res 2009 84 33 41
9. The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling. KB Shah MK Duda KM O'shea GC Sparagna DJ Chess RJ Khairallah, et al. Hypertension 2009 54 605 611
10. A High Fat Diet Increases Adiposity but Maintains Mitochondrial Oxidative Enzymes without Affecting Development of Heart Failure with Pressure Overload. DJ Chess RJ Khairallah KM O'shea W Xu WC Stanley, Am J Physiol Heart Circ Physiol 2009 297 1585 1593
11. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. A Garnier D Fortin C Delomenie I Momken V Veksler R Ventura-Clapier, J Physiol 2003 551 491 501
12. Nuclear receptor signaling and cardiac energetics. JM Huss DP Kelly, Circ Res 2004 95 568 578
13. Adiponectin actions in the cardiovascular system. TA Hopkins N Ouchi R Shibata K Walsh, Cardiovasc Res 2007 74 11 18
14. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. S Neschen K Morino JC Rossbacher RL Pongratz GW Cline S Sono, et al. Diabetes 2006 55 924 928
15. n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. O Kuda T Jelenik Z Jilkova P Flachs M Rossmeisl M Hensler, et al. Diabetologia 2009 52 941 951
16. Adiponectin and risk of congestive heart failure. E Ingelsson U Riserus C Berne J Frystyk A Flyvbjerg T Axelsson, et al. JAMA 2006 295 1772 1774 %19
17. Circulating adiponectin concentrations in patients with congestive heart failure. J George S Patal D Wexler Y Sharabi E Peleg Y Kamari, et al. Heart 2006 92 1420 1424
18. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. DS Frankel RS Vasan RB D'Agostino Sr EJ Benjamin D Levy TJ Wang, et al. J Am Coll Cardiol 2009 53 754 762
19. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. C Kistorp J Faber S Galatius F Gustafsson J Frystyk A Flyvbjerg, et al. Circulation 2005 112 1756 1762
20. Adiponectin-mediated modulation of hypertrophic signals in the heart. R Shibata N Ouchi M Ito S Kihara I Shiojima DR Pimentel, et al. Nat Med 2004 10 1384 1389
21. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Y Liao S Takashima N Maeda N Ouchi K Komamura I Shimomura, et al. Cardiovasc Res 2005 67 705 713
22. Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload. KM O'Shea DJ Chess RJ Khairallah S Rastogi PA Hecker HN Sabbah, et al. Am J Physiol Heart Circ Physiol 2010 298 1639 H1645
23. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. N Maeda I Shimomura K Kishida H Nishizawa M Matsuda H Nagaretani, et al. Nat Med 2002 8 731 737
24. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. P Hu D Zhang L Swenson G Chakrabarti ED Abel SE Litwin, Am J Physiol Heart Circ Physiol 2003 285 1261 H1269
25. Direct transesterification of all classes of lipids in a one-step reaction. G Lepage CC Roy, J Lipid Res 1986 27 114 120
26. Low carbohydrate/high fat diet attenuates pressure overload induced ventricular remodeling and dysfunction. MK Duda KM O'Shea B Lei BR Barrows AM Azimzadeh TE McElfresh, et al. J Card Fail 2007 14 327 335
27. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. M Itoh T Suganami N Satoh K Tanimoto-Koyama X Yuan M Tanaka, et al. Arterioscler Thromb Vasc Biol 2007 27 1918 1925
28. Dietary fish oil did not prevent sleep deprived rats from a reduction in adipose tissue adiponectin gene expression. AB de Mattos MJ Pinto C Oliveira C Biz EB Ribeiro CM do Nascimento, et al. Lipids Health Dis 2008 7 43 43
29. Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives. M Rossmeisl T Jelenik Z Jilkova K Slamova V Kus M Hensler, et al. Obesity (Silver Spring) 2009 17 1023 1031
30. PPAR signaling in the control of cardiac energy metabolism. PM Barger DP Kelly, Trends Cardiovasc Med 2000 10 238 245
31. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. B Lei V Lionetti ME Young MP Chandler C D'Agostino E Kang, et al. J Mol Cell Cardiol 2004 36 567 576
32. Dissociation between gene and protein expression of metabolic enzymes in a rodent model of heart failure. EE Morgan MP Chandler ME Young TA McElfresh TA Kung JH Rennison, et al. Eur J Heart Fail 2006 8 687 693
33. Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+induced permeability transition. KM O'Shea RJ Khairallah GC Sparagna W Xu PA Hecker I Robillard-Frayne, et al. J Mol Cell Cardiol 2009 47 819 827
34. Myocardial substrate metabolism in the normal and failing heart. WC Stanley FA Recchia GD Lopaschuk, Physiol Rev 2005 85 1093 1129
35. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. WS Harris SA Sands SL Windsor HA Ali TL Stevens A Magalski, et al. Circulation 2004 110 1645 1649
36. Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies. GE Billman Y Nishijima AE Belevych D Terentyev Y Xu KM Haizlip, et al. Am J Physiol Heart Circ Physiol 2010 298 1219 H1228
37. Artificial rearing of infant mice leads to n-3 fatty acid deficiency in cardiac, neural and peripheral tissues. N Hussein I Fedorova T Moriguchi K Hamazaki HY Kim J Hoshiba, et al. Lipids 2009 44 685 702